Incorporating Quantitative Patient Preference Data into Healthcare Decision Making Processes: Is HTA Falling Behind? David John Mott Editorial 02 March 2018 Pages: 249 - 252
Experience-Based Values: A Framework for Classifying Different Types of Experience in Health Valuation Research Patricia Cubi-MollaKoonal ShahKristina Burström Leading Article 05 January 2018 Pages: 253 - 270
Factors that Influence Treatment and Non-treatment Decision Making Among Individuals with Inflammatory Bowel Disease: An Integrative Review Kendra J. KampKelly Brittain Review Article 08 January 2018 Pages: 271 - 284
Evaluating Risk Tolerance from a Systematic Review of Preferences: The Case of Patients with Psoriasis Juan Marcos Gonzalez Systematic Review 13 January 2018 Pages: 285 - 300
A Systematic Review Comparing the Acceptability, Validity and Concordance of Discrete Choice Experiments and Best–Worst Scaling for Eliciting Preferences in Healthcare Jennifer A. WhittyAna Sofia Oliveira Gonçalves Systematic Review 25 November 2017 Pages: 301 - 317
Experience of Symptoms and Disease Impact in Patients with Adenomyosis Linda M. NelsenWilliam R. LenderkingAndrea S. Lukes Original Research Article Open access 02 December 2017 Pages: 319 - 328
Mapping Quality of Life (EQ-5D) from DAPsA, Clinical DAPsA and HAQ in Psoriatic Arthritis Tomas MlcochJan TuzilTomas Dolezal Original Research Article 21 November 2017 Pages: 329 - 340
Impact of Canagliflozin Treatment on Health-Related Quality of Life among People with Type 2 Diabetes Mellitus: A Pooled Analysis of Patient-Reported Outcomes from Randomized Controlled Trials Jennifer CaiLinda M. DelahantyShana Traina Original Research Article Open access 08 January 2018 Pages: 341 - 352
Engagement of Canadian Patients with Rare Diseases and Their Families in the Lifecycle of Therapy: A Qualitative Study Andrea YoungDevidas MenonTania Stafinski Original Research Article 03 January 2018 Pages: 353 - 359
Satisfaction with Subcutaneous Golimumab and its Auto-Injector among Rheumatoid Arthritis Patients with Inadequate Response to Adalimumab or Etanercept Raphael J. DehoratiusLawrence H. BrentKezhen L. Tang Original Research Article Open access 09 February 2018 Pages: 361 - 369